Insiders Seres Therapeutics, Inc.

Equities

MCRB

US81750R1023

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
0.9199 ^USD	-0.49%		-10.69%	-34.29%

May. 09	Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating	MT
May. 09	Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seres Therapeutics Appoints Marella Thorell as Executive Vice President	Feb. 26	CI
Grégory Behar Resigns from Board of Directors of Seres Therapeutics, Inc	23-10-04	CI
Seres Therapeutics, Inc. Announces the Appointment of Claire M. Fraser, Ph.D., to Its Board of Directors	23-01-05	CI
Seres Therapeutics Appoints Paula Cloghessy as Executive Vice President, Chief People Officer	22-02-08	CI
Seres Therapeutics, Inc. Announces Management Changes	21-05-20	CI
Seres Therapeutics, Inc. Appoints David Arkowitz as Chief Financial Officer, Effective June 1, 2021	21-05-20	CI
Seres Therapeutics Announces Executive Appointments	20-10-22	CI
Seres Therapeutics Appoints Terri Young as Executive Vice President, Chief Commercial and Strategy Officer	20-06-22	CI
Seres Therapeutics, Inc. Appoints Lisa Von Moltke as Executive Vice President and Chief Medical Officer	20-04-06	CI
Seres Therapeutics, Inc. Announces Executive Changes	20-03-23	CI
Seres Therapeutics, Inc. Appoints Stephen Berenson as Chairman of Its Board of Directors	19-12-16	CI
Seres Therapeutics Appoints Stephen Berenson to its Board of Directors	19-08-06	CI
Seres Therapeutics, Inc. Appoints Marcus Chapman as Principal Financial and Accounting Officer of the Company	19-04-18	CI
Seres Therapeutics, Inc. Announces Executive Changes	19-02-07	CI
Seres Therapeutics, Inc. Announces Executive Changes	19-01-15	CI
Seres Therapeutics, Inc. Announces Resignation of Michele Trucksis as Executive Vice President and Chief Medical Officer	18-11-21	CI
Seres Therapeutics, Inc. Announces Management Changes	18-10-22	CI
Seres Therapeutics, Inc. Announces Appointment of Meryl Zausner to Board of Directors	18-09-04	CI
Seres Therapeutics, Inc. Announces Appointment of Eric D. Shaff to Additional Role of Chief Operating Officer	18-01-31	CI
Seres Therapeutics, Inc. Elects Willard H. Dere as a Class I Director and Member of the Audit Committee of the Board	17-07-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Seres Therapeutics, Inc.

Equities

MCRB

US81750R1023

Insiders

Filters